Skip to main content

Table 6 Clinical outcomes and hospital resource use

From: Early versus later response to treatment in patients with community-acquired pneumonia: analysis of the REACH study

Outcome, n (%)

Early responders n = 332

Later responders n = 253

Patients without Halm-based assessment of TCS n = 1454

Antibiotic treatment modification while on initial therapy (excluding streamlining*)

47 (14.2)

88 (34.8)

454 (31.2)

Time to clinical stability, days, mean (SD) [median]

2.6 (0.95) [3.0]

9.0 (6.53) [7.0]

5.7 (5.0) [5.0]

Length of stay, days, mean (SD) [median]

9.4 (7.0) [8.0] (n = 309)

15.6 (10.5) [12.0] (n = 246)

12.6 (10.7) [10.0] (n = 1423)

Length of stay after achievement of clinical stability, days, mean (SD) [median]

5.9 (7.1) [4.0] (n = 305)

5.9 (7.0) [3.0] (n = 231)

N/A

Patients admitted to ICU

11 (3.3)

54 (21.3)

213 (14.6)

Time in ICU, days, mean (SD) [median] (n)

6.2 (5.7) [4.0] (n = 11)

10.4 (10.1) [8.0] (n = 53)

9.5 (12.4) [5.0]

Patients admitted to ICU after achievement of clinical stability

0

1 (0.4)

N/A

Reinfection/recurrence§

11 (3.3)

15 (5.9)

68 (4.7)

Home-based care after discharge

6 (1.8)

11 (4.3)

56 (3.9)

Blood pressure support during hospitalization

   

 Fluid resuscitation

24 (7.2)

37 (14.6)

190 (13.1)

 Vasopressors

2 (0.6)

17 (6.7)

82 (5.6)

 Invasive procedures

1 (0.3)

3 (1.2)

26 (1.8)

Isolation required

28 (8.4)

24 (9.5)

102 (7.0)

Mechanical ventilation required during hospitalization

24 (7.2)

48 (19.0)

208 (14.3)

 Invasive

12 (3.6)

28 (11.1)

99 (6.8)

 Non-invasive

12 (3.6)

25 (9.9)

129 (8.9)

Parenteral nutrition

5 (1.5)

19 (7.5)

70 (4.8)

Duration of parenteral nutrition, days, mean (SD) [median]

6.0 (3.5) [5.0] (n = 5)

8.2 (5.1) [6.5] (n = 18)

9.5 (12.0) [5.0] (n = 65)

Acute renal failure necessitating renal replacement therapy

1 (0.3)

6 (2.4)

39 (2.7)

Duration of renal failure, days, mean (SD) [median]

2.0 (0) [2.0] (n = 1)

14.3 (16.0) [9.5] (n = 4)

5.7 (7.2) [3.0] (n = 32)

Septic shock during hospitalization

1 (0.3)

20 (7.9)

63 (4.3)

Mortality

2 (0.6)

4 (1.6)

141 (9.7)

Post-discharge mortality

0

0

0

  1. *De-escalation of treatment to narrower-spectrum antibiotics upon patient improvement or confirmed microbiological diagnosis.
  2. Includes duration of all hospitalizations for patients with recurrences.
  3. Does not include duration of all hospitalizations for patients with recurrences.
  4. §Refers to patients hospitalized again (due to CAP) after initial discharge.
  5. ICU = intensive care unit; N/A = not applicable; SD = standard deviation.